Newsfeeds - Spark Newswire

1 minute read

News

Mirati Therapeutics Clinical Research at ESMO Congress 2021 to Highlight Progress with Investigational Adagrasib and Sitravatinib in Patients with Lung and Colorectal Cancers

Today, 9:43 AM

Mirati Therapeutics, Inc. (NASDAQ:MRTX), a clinical-stage targeted oncology company, today announced two oral presentations of clinical data will be presented at the upcoming European Society for Medical Oncology

MRTX

1 minute read

HC Wainwright & Co. Maintains Buy on Mirati Therapeutics, Lowers Price Target to $247

By Benzinga Newsdesk

Today, 9:43 AM

HC Wainwright & Co. analyst Edward White maintains Mirati Therapeutics (NASDAQ:MRTX) with a Buy and lowers the price target from $251 to $247.

MRTX

1 minute read

Mirati Therapeutics Q2 EPS $(3.23) Down From $(1.89) YoY

By Bill Haddad

Today, 9:43 AM

Mirati Therapeutics (NASDAQ:MRTX) reported quarterly losses of $(3.23) per share. This is a 70.9 percent decrease over losses of $(1.89) per share from the same period last year.

MRTX

1 minute read

FDA
News

Mirati Therapeutics Posts Study Titled ‘Phase 1/1B Study in Patients With Cancer KRYSTAL 14’ To ClinicalTrials.Gov; Study Is Recruiting

By Benzinga Newsdesk

Today, 9:43 AM

https://clinicaltrials.gov/ct2/show/NCT04975256

MRTX

1 minute read

Mirati’s KRAS Inhibitor Receives FDA Breakthrough Tag For Lung Cancer Harboring KRAS Mutation

By Vandana Singh

Today, 9:43 AM

The FDA has granted Breakthrough Therapy designation to Mirati Therapeutics Inc’s (NASDAQ:MRTX) adagrasib in non-small cell lung cancer (NSCLC) patients with the…

MRTX

5 minute read

The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs

By Shanthi Rexaline

Today, 9:43 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24)

ABBV

2 minute read

20 Stocks Moving in Friday’s Pre-Market Session

By Lisa Levin

Today, 9:43 AM

Gainers Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) rose 83.4% to $16.34 in pre-market trading after the company reported a sharp rise in Q1 earnings and sales.

AEMD

2 minute read

A Peek Into The Markets: US Stock Futures Up Following Thursday’s Rally; Nike Posts Upbeat Results

By Lisa Levin

Today, 9:43 AM

Pre-open movers

1 minute read

7 Stocks Moving In Thursday’s After-Hours Session

By Tyree Gorges

Today, 9:43 AM

Gainers Mirati Therapeutics (NASDAQ: MRTX) shares are trading higher after the company announced it received Breakthrough Therapy Designation from the FDA for patients with advanced non-small cell lung cancer harboring the KRAS G12C mutation.

FDX

1 minute read

FDA
News

Mirati Therapetuics Reports Its Adagrasib Received Breakthrough Therapy Designation From FDA For Patients With Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation

By Benzinga Newsdesk

Today, 9:43 AM

Mirati Therapeutics, Inc. (NASDAQ:MRTX), a clinical-stage targeted oncology company, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to adagrasib for the

MRTX